Protagenic Therapeutics (PTIX) Stock Soars 240% On Phytanix Merger - Protagenic Therapeutics (NASDAQ:PTIX)

Mergers & acquisitions News

Protagenic Therapeutics shares soared 240% Monday on its all-stock merger with Phytanix Bio. New Phytanix targets CNS disorders with an expanded ...

Related articles